Point mutations that selectively eliminate XPG nuclease activity cause XP, while C-terminal truncations, destabilizing point mutations, and mutations that abolish the interaction between XPG and the basal transcription factor TFIIH cause XP/CS and COFS [52]–[58]. The gene discussed is ERCC3; the disease is xeroderma pigmentosum.